We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,506 results
  1. HIV drug resistance to integrase inhibitors in low- and middle-income countries

    Joseph Fokam, Seth Inzaule, ... Nicaise Ndembi in Nature Medicine
    Article 23 January 2024
  2. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection

    Integrase strand transfer inhibitors (INSTIs) have improved the treatment of human immunodeficiency virus (HIV). There are currently four approved...

    Alexa Vyain Zhao, Rustin D. Crutchley, ... Amy Cheng Min in Retrovirology
    Article Open access 22 October 2022
  3. Integrase Inhibitors are Associated with Neuropsychiatric Symptoms in Women with HIV

    Objective

    Women with HIV(WWH) are more likely to discontinue/change antiretroviral therapy(ART) due to side effects including neuropsychiatric...

    Leah H. Rubin, Jane A. O’Halloran, ... Yanxun Xu in Journal of Neuroimmune Pharmacology
    Article 17 February 2022
  4. Potential drug–drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan

    Background

    Potential drug–drug interactions (PDDIs) commonly occur because of aging and comorbidities in people living with human immunodeficiency...

    Yusuke Kunimoto, Ryosuke Matamura, ... Masahide Fukudo in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 01 December 2021
  5. Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus

    The targeted insertion and stable expression of a large genetic payload in primary human cells demands methods that are robust, efficient and easy to...

    Michael Chavez, Draven A. Rane, ... Lei S. Qi in Nature Biomedical Engineering
    Article 01 May 2023
  6. LEDGINs, Inhibitors of the Interaction Between HIV-1 Integrase and LEDGF/p75, Are Potent Antivirals with a Potential to Cure HIV Infection

    A permanent cure remains the greatest challenge in the field of HIV research. In order to reach this goal, a profound understanding of the molecular...
    Zeger Debyser, Anne Bruggemans, ... Frauke Christ in Antiviral Drug Discovery and Development
    Chapter 2021
  7. Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor

    Background

    Integrase (IN) is an essential protein for HIV replication that catalyzes insertion of the reverse-transcribed viral genome into the host...

    Ki Hoon Park, Minjee Kim, ... Young Bong Kim in Virology Journal
    Article Open access 13 January 2021
  8. Carboxylated chalcones and related flavonoids as inhibitors of xanthine oxidase

    Carboxylated chalcones and other related flavonoids were synthesized and evaluated as inhibitors of xanthine oxidase, which is a known target for...

    Oleksandr L. Kobzar, Alona V. Tatarchuk, ... Andriy I. Vovk in Medicinal Chemistry Research
    Article 28 June 2023
  9. Influence of the amino-terminal sequence on the structure and function of HIV integrase

    Background

    Antiretroviral therapy (ART) can mitigate the morbidity and mortality caused by the human immunodeficiency virus (HIV). Successful...

    Grant Eilers, Kushol Gupta, ... Gregory Van Duyne in Retrovirology
    Article Open access 31 August 2020
  10. HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors

    The human T-lymphotropic virus type 1 (HTLV-1) infects millions of people globally and is endemic to various resource-limited regions. Infections...

    Nicolas Tardiota, Noushin Jaberolansar, ... Jake S. O’Donnell in Virology Journal
    Article Open access 10 January 2024
  11. Suppression of HIV-1 Integration by Targeting HIV-1 Integrase for Degradation with A Chimeric Ubiquitin Ligase

    Human immunodeficiency virus (HIV) attacks human immune system and causes life-threatening acquired immune deficiency syndrome (AIDS). Treatment with...

    Zuopeng Zhang, Sen Yuan, ... Min Wang in Virologica Sinica
    Article 13 November 2020
  12. HIV-1 integrase binding to genomic RNA 5′-UTR induces local structural changes in vitro and in virio

    Background

    During HIV-1 maturation, Gag and Gag-Pol polyproteins are proteolytically cleaved and the capsid protein polymerizes to form the honeycomb...

    Shuohui Liu, Pratibha C. Koneru, ... Karin Musier-Forsyth in Retrovirology
    Article Open access 22 November 2021
  13. In silico approaches for study the therapeutic potential of Cannabis sativa (Bhang) against HIV

    Human Immunodeficiency Virus (HIV) is one of the world's most significant public health issues. HIV become severe in the COVID pandemic. Scientists...

    Versha Kajal, Sanjit Boora, ... Samander Kaushik in Advances in Traditional Medicine
    Article 04 August 2023
  14. Recent Updates on In Silico Screening of Natural Products as Potential Inhibitors of Enzymes of Biomedical and Pharmaceutical Importance

    Natural products from medicinal plants have been increasingly used in modern medicine due to their safety, efficacy, and lesser toxicity. World over,...
    Mohini Patil, Samadhan Patil, ... Ravindra H. Patil in Natural Products as Enzyme Inhibitors
    Chapter 2022
  15. The Role of Immune Checkpoint Inhibitors in the Treatment of Less Common Head and Neck Cancers

    The role of immune checkpoint inhibitors in less common head and neck cancers, including non-squamous cell carcinoma, is less known. This chapter...
    Stefano Cavalieri, Paolo Bossi, Lisa Licitra in Immunotherapy for Head and Neck Cancer
    Chapter 2022
  16. DNA sequence-specific ligands. XX. Synthesis, spectral properties, virological and biochemical studies of fluorescent dimeric trisbenzimidazoles DB3P(n)

    A new series of AT-specific minor groove DNA ligands (DB 3 P( n ); n = 1,2,3,4) was synthesized and their spectral, biological and virological properties...

    Albert F. Arutyunyan, Alexey A. Kostyukov, ... Alexei L. Zhuze in Medicinal Chemistry Research
    Article 03 February 2023
  17. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection

    Background

    Several anti-retroviral drugs are available against Human immunodeficiency virus type-1, but have multiple adverse side effects. Hence,...

    Pratiksha Jadaun, R Harshithkumar, ... Anupam Mukherjee in Virology Journal
    Article Open access 03 August 2023
  18. Synergistic Herb-Drug Interactions Against Viral Diseases

    Emerging or reemerging viruses are of serious concern as they are associated with higher degree of mortality and deleterious impact on human life....
    Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble in Herb-Drug Combinations
    Chapter 2022
  19. Re-evaluating the relationship between youth with HIV and BMI in an age of increasing rates of overweight and obese youth

    Background

    Newer antiretrivirals (ART) have shifted the metabolic experiences of people with HIV (PWH) from those of wasting syndrome to increases in...

    Samantha V. Hill, Jiaying Hao, ... Tina Simpson in BMC Research Notes
    Article Open access 01 April 2024
  20. Histone deacetylase 1 interacts with HIV-1 Integrase and modulates viral replication

    Background

    HIV-1 hijacks the cellular machinery for its own replication through protein-protein interactions between viral and host cell factors. One...

    Fadila Larguet, Clément Caté, ... Elsy Edouard in Virology Journal
    Article Open access 19 November 2019
Did you find what you were looking for? Share feedback.